Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease

Derek Leong1, Benita Tjoe1, Parham Zarrini1

  • 1Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States of America.

Insights

Women with ischemia and no obstructive coronary artery disease (INOCA) face higher heart failure (HF) risks. Novel predictors include high IL-6, low coronary flow reserve, and poor functional status, aiding future prevention strategies.

Area of Science:

  • Cardiology
  • Women's Health
  • Heart Failure Research

Background:

  • Women with ischemia and no obstructive coronary artery disease (INOCA) have increased risk for heart failure (HF) hospitalizations, primarily HF with preserved ejection fraction (HFpEF).
  • Identifying predictors for HF development in this population is crucial for targeted interventions.

Purpose of the Study:

  • To identify predictors for heart failure (HF) development in women with ischemia and no obstructive coronary artery disease (INOCA).
  • To analyze long-term prospective follow-up data from a deeply phenotyped cohort of women with INOCA.

Main Methods:

  • Utilized data from 493 women in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
  • Employed multivariate Cox analysis to assess associations between baseline characteristics and HF hospitalizations.
  • Considered clinical history, medications, physical exam, laboratory data, and angiographic data, including coronary flow reserve (CFR).

Main Results:

  • During a median 6-year follow-up, 3.7% of women were hospitalized for HF.
  • Diabetes mellitus and tobacco use were associated with HF hospitalization.
  • Novel predictors identified included higher resting heart rate, multi-parity, elevated IL-6 levels, lower CFR, and poor functional status, independent of traditional HFpEF risk factors.

Conclusions:

  • Women with INOCA have a considerable incidence of long-term HF hospitalization.
  • Novel risk factors such as multi-parity, high IL-6, low CFR, and poor functional status independently predict HF hospitalization.
  • These findings may inform mechanistic understanding and future treatment targets for preventing HFpEF in women.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.6K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370